Sleep-disordered breathing associated with long-term opioid therapy

Area of Science:

• Pulmonology
• Sleep Medicine
• Pharmacology

Background:

• Opioid medications are frequently prescribed for chronic pain management.
• Long-term opioid use may affect respiratory function during sleep.
• Distinct patterns of sleep-disordered breathing (SDB) have been anecdotally observed in patients on sustained-release opioids.

Observation:

• This study describes three patients on long-term, sustained-release opioid therapy exhibiting specific SDB patterns.
• Polysomnography revealed respiratory disturbances predominantly during non-rapid eye movement (NREM) sleep.
• Observed disturbances included ataxic breathing, central apneas, sustained hypoxemia, and prolonged obstructive hypopneas due to delayed arousal.

Findings:

• Opioid-induced SDB during NREM sleep is characterized by severe oxygen desaturation and prolonged respiratory events.
• These findings contrast with typical obstructive sleep apnea (OSA) patterns, where events are often more severe during rapid eye movement (REM) sleep.
• Delayed arousal responses appear to contribute to the prolonged hypopneas observed.

Implications:

• Opioid medications can significantly alter respiratory control during sleep, leading to unique SDB phenotypes.
• Clinical awareness of these opioid-induced respiratory disturbances is crucial for accurate diagnosis and management.
• Further research is warranted to elucidate the mechanisms and clinical significance of opioid effects on sleep respiration, including drug interactions and OSA risk factors.